Oscar Health Shares Dip 0.16% with $290M Volume Ranking 437th in Market

Oscar Health (OSCR) fell 0.16% on October 1, 2025, with a trading volume of $0.29 billion, ranking 437th in the market by volume. The stock's muted performance contrasted with broader market trends, as investors appeared to focus on sector-specific dynamics rather than macroeconomic catalysts.

Analysts noted the stock's low trading volume relative to its price movement, suggesting limited liquidity or reduced institutional activity. The volume rank indicates OSCR remains a niche player in the healthcare technology space, with trading activity insufficient to drive significant directional shifts. Market participants may be awaiting further guidance from upcoming earnings or regulatory updates to assess long-term positioning.

To construct an accurate back-test, key parameters must be defined: the universe of stocks (e.g., NYSE + NASDAQ + AMEX-listed equities), position sizing methodology (equal-weight or volume/market-cap weighted), rebalancing rules (intraday holds or overnight positions), and transaction-cost assumptions. Additionally, benchmark comparisons (e.g., SPY) and risk controls (stop-loss limits) require specification before executing the strategy. These details will determine the back-test's validity and actionable insights for portfolio optimization.